Suppr超能文献

相似文献

2
Delimitation of a critical tumour suppressor region at distal 1p in neuroblastoma tumours.
Eur J Cancer. 1997 Oct;33(12):1997-2001. doi: 10.1016/s0959-8049(97)00278-5.
3
Representational difference analysis and loss of heterozygosity studies detect 3p deletions in neuroblastoma.
Eur J Cancer. 1997 Oct;33(12):1966-70. doi: 10.1016/s0959-8049(97)00228-1.
4
Investigation of tumor suppressor genes apart from VHL on 3p by deletion mapping in sporadic clear cell renal cell carcinoma (cRCC).
Urol Oncol. 2013 Oct;31(7):1333-42. doi: 10.1016/j.urolonc.2011.08.012. Epub 2011 Oct 1.
9
Reduced Fhit protein expression in human malignant mesothelioma.
Virchows Arch. 2004 Jan;444(1):43-8. doi: 10.1007/s00428-003-0902-3. Epub 2003 Oct 16.
10
Loss of heterozygosity for chromosome 14q in neuroblastoma.
Med Pediatr Oncol. 2001 Jan;36(1):28-31. doi: 10.1002/1096-911X(20010101)36:1<28::AID-MPO1008>3.0.CO;2-0.

引用本文的文献

1
Difluoromethylornithine (DFMO) and Neuroblastoma: A Review.
Cureus. 2023 Apr 17;15(4):e37680. doi: 10.7759/cureus.37680. eCollection 2023 Apr.
2
Gene Expression Signature of Acquired Chemoresistance in Neuroblastoma Cells.
Int J Mol Sci. 2020 Sep 16;21(18):6811. doi: 10.3390/ijms21186811.
3
gene acts as a tumor suppressor in human neuroblastoma.
Oncotarget. 2018 May 25;9(40):25903-25921. doi: 10.18632/oncotarget.25403.
4
Constitutional 3p26.3 terminal microdeletion in an adolescent with neuroblastoma.
Cancer Biol Ther. 2017 May 4;18(5):285-289. doi: 10.1080/15384047.2017.1312231. Epub 2017 Apr 12.
5
Multiple mechanisms disrupt the let-7 microRNA family in neuroblastoma.
Nature. 2016 Jul 14;535(7611):246-51. doi: 10.1038/nature18632. Epub 2016 Jul 6.
7
Molecular and genetic bases of neuroblastoma.
Int J Clin Oncol. 2012 Jun;17(3):190-5. doi: 10.1007/s10147-012-0415-7. Epub 2012 May 16.
8
The connections between neural crest development and neuroblastoma.
Curr Top Dev Biol. 2011;94:77-127. doi: 10.1016/B978-0-12-380916-2.00004-8.
10
Chromosomal CGH identifies patients with a higher risk of relapse in neuroblastoma without MYCN amplification.
Br J Cancer. 2007 Jul 16;97(2):238-46. doi: 10.1038/sj.bjc.6603820. Epub 2007 Jun 19.

本文引用的文献

1
The International Neuroblastoma Risk Groups (INRG): a preliminary report.
Eur J Cancer. 1997 Oct;33(12):2113-6. doi: 10.1016/s0959-8049(97)00202-5.
2
Representational difference analysis and loss of heterozygosity studies detect 3p deletions in neuroblastoma.
Eur J Cancer. 1997 Oct;33(12):1966-70. doi: 10.1016/s0959-8049(97)00228-1.
3
Homozygous deletion of the neurofibromatosis-1 gene in the tumor of a patient with neuroblastoma.
Cancer Genet Cytogenet. 1997 Jun;95(2):183-9. doi: 10.1016/s0165-4608(96)00259-2.
7
A comprehensive genetic map of the human genome based on 5,264 microsatellites.
Nature. 1996 Mar 14;380(6570):152-4. doi: 10.1038/380152a0.
9
Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.
J Clin Oncol. 1993 Aug;11(8):1466-77. doi: 10.1200/JCO.1993.11.8.1466.
10
A first-generation physical map of the human genome.
Nature. 1993 Dec 16;366(6456):698-701. doi: 10.1038/366698a0.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验